- Home
- Cancer Nanopore Day, Sydney 2023
Event overview
Hear about the latest technical updates for Oxford Nanopore Technologies as well as talks from local scientists about their latest work using nanopore technology.
There will also be an opportunity to submit questions throughout the talks, which will be answered in the Q&A sessions following each presentation.
Please note that this is an in-person event.
There is no delegate fee for this event, but registration is required. Your place at this event will be confirmed via email from events@nanoporetech.com.
Agenda
Time | Agenda | Speaker |
---|---|---|
9:30 - 10:00 | Registration | |
10:00 - 10:05 | An introduction to Oxford Nanopore | Warren Bach Oxford Nanopore Technologies |
10:05 - 10:30 | Cancer whole genome analysis with Oxford Nanopore Sequencing | Nic Waddell QIMR Berghofer Medical Research Institute |
10:30 - 10:55 | Investigating structural variations and complex cancer genomes using Oxford Nanopore Sequencing | Marjan M. Naeini Garvan Institute of Medical Research |
10:55 - 11:20 | Unravelling rDNA Methylation Patterns and UBF Binding in Malignant Transformations | Zaka Wing-Sze Yuen The John Curtin School of Medical Research, Australian National University EMBL Australian Partner Laboratory Network at the Australian National University |
11:20 - 11:45 | Dissecting the impacts of gene fusion-mediated translational dysregulation in B-cell lymphoblastic leukemia to highlight novel therapeutic | Nickolay Shirokikh Australian National University |
11:45 - 12:10 | Long-read mobile DNA methylomes | Geoff Faulkner University of Queensland |
12:10 - 13:00 | Lunch Mixer | |
13:00 - 13:50 | Single molecule cancer genomics from individual cell mutation detection and engineering to cell free tumor detection | Hanlee Ji Stanford University |
13:50 - 14:15 | Deciphering cancer through long read bulk and single cell transcriptomic analysis: opportunities and challenges | Nadia Davidson Walter and Eliza Hall Institute |
14:15 - 14:40 | The Benefits of Long Read Sequencing for Haematological Malignancy Assessment | Rodney Scott Hunter Medical Research Institute (HMRI) |
14:40 - 15:10 | Afternoon tea | |
15:10 - 15:35 | Long-read single-cell RNA sequencing in clonal haematopoiesis | Owen Siggs Garvan Institute of Medical Research |
15:35 - 15:55 | Technical and Bioinformatics updates from Oxford Nanopore | Miles Benton Oxford Nanopore Technologies |
15:55 - 16:00 | Closing remarks | Warren Bach Oxford Nanopore Technologies |
16:00 - 17:30 | Social Mixer (with refreshments) |
Speakers
)
Cancer whole genome analysis with Oxford Nanopore Sequencing
Nic Waddell, QIMR Berghofer Medical Research Institute
...
)
Investigating structural variations and complex cancer genomes using Oxford Nanopore Sequencing
Marjan M. Naeini, Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research St Vincent’s Clinical School, University of New South Wales
Dr Naeini completed a PhD in genetics and computational biology at Genome Institute of Singapore, AS...
)
Unravelling rDNA Methylation Patterns and UBF Binding in Malignant Transformations
Zaka Wing-Sze Yuen, The John Curtin School of Medical Research, Australian National University. EMBL Australian Partner Laboratory Network at the Australian National University
Zaka is a Postdoc in Prof. Eduardo Eyras’s lab at the Australian National University (ANU), working ...
)
Dissecting the impacts of gene fusion-mediated translational dysregulation in B-cell lymphoblastic leukemia to highlight novel therapeutic
Nickolay Shirokikh, Australian National University
Dr Shirokikh is a group leader and NHMRC Emerging Leadership Fellow at the John Curtin School of Med...
)
Long-read mobile DNA methylomes
Geoff Faulkner, University of Queensland
Professor Geoff Faulkner is a computational biologist with interests in mobile DNA, cancer genomics ...
)
Single molecule cancer genomics from individual cell mutation detection and engineering to cell free tumor detection
Hanlee Ji, Stanford University
Dr. Ji is a Physician Scientist and Professor at Stanford University. His clinical interests and pra...
)
Deciphering cancer through long read bulk and single cell transcriptomic analysis: opportunities and challenges
Nadia Davidson, Walter and Eliza Hall Institute
Dr. Nadia Davidson currently leads a bioinformatics research group at the Walter and Eliza Hall Inst...
)
The Benefits of Long Read Sequencing for Haematological Malignancy Assessment
Rodney Scott , Hunter Medical Research Institute (HMRI)
...
)
Long-read single-cell RNA sequencing in clonal haematopoiesis
Owen Siggs , Garvan Institute of Medical Research
...